Coronary Stents Market Research Report with Value, Data, and News 2025-2032
Coronary Stents Market was Valued at USD 8.3 Bn. in 2024 and the total revenue is expected to grow at CAGR of 7.6% from 2025 to 2032 Reaching nearly USD 14.91 Bn. by 2032
Coronary Stents Market Overview
Coronary stents are expandable, tubular medical devices—typically made of metal or bioresorbable materials—used to restore blood flow in coronary arteries narrowed or blocked by atherosclerosis. These devices are implanted during a minimally invasive revascularization procedure known as percutaneous coronary intervention (PCI), also referred to as coronary angioplasty with stent placement. PCI has become a cornerstone therapy for managing coronary artery disease (CAD), reducing symptoms such as angina and lowering the risk of myocardial infarction.
The global coronary stents market is experiencing steady growth, driven by the rising prevalence of cardiovascular diseases (CVDs), increasing volumes of PCI procedures, and continuous advancements in stent design and materials. Aging populations, sedentary lifestyles, and the global rise in metabolic disorders such as diabetes and hypertension are significantly increasing the patient pool requiring coronary interventions.
Drug-eluting stents (DES) currently dominate the market due to their superior clinical outcomes, including lower restenosis rates and improved long-term vessel patency. In contrast, bare-metal stents (BMS) are witnessing declining demand. Meanwhile, bioresorbable vascular scaffolds (BVS) and dual-therapy stents (DTS) are emerging as innovative alternatives aimed at improving vascular healing and long-term patient outcomes.
North America leads the global market due to advanced healthcare infrastructure, strong reimbursement frameworks, and high adoption of minimally invasive cardiology procedures. The Asia-Pacific region represents the fastest-growing market, fueled by rising healthcare expenditure, expanding access to interventional cardiology, and increasing patient awareness in countries such as China and India.
Leading manufacturers—including Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and Terumo Corporation—continue to invest heavily in research and development to introduce next-generation stent technologies. Future innovation is expected to focus on biodegradable stents, nanotechnology-based coatings, and artificial-intelligence-assisted procedural planning, supporting continued market evolution and improved patient care.
Download your complimentary sample copy of this report! https://www.stellarmr.com/report/req_sample/coronary-stents-market/2685
Coronary Stents Market Dynamics
High Incidence of Obesity and Diabetes Driving Market Growth
The global rise in obesity and diabetes is a major driver of demand for coronary stents. More than one billion people worldwide are affected by obesity, a figure that continues to increase due to sedentary lifestyles and unhealthy dietary habits. Obesity and diabetes are among the most significant risk factors for coronary artery disease, contributing to plaque buildup within arteries and increasing the likelihood of heart attacks and other cardiovascular complications that require PCI procedures.
According to the Centers for Disease Control and Prevention, obesity prevalence among adults in the United States has exceeded 40%. As the incidence of these conditions rises globally, so does the demand for coronary stent implantation. Preventive healthcare initiatives and early diagnostic screening programs are further contributing to increased detection of high-risk individuals and subsequent interventional treatment.
Recommendations from the U.S. Preventive Services Task Force for cholesterol and blood pressure screening among adults aged 40–75 have accelerated early diagnosis of coronary artery disease, indirectly supporting growth in stent placement procedures.
High Procedure Costs Limiting Market Expansion
Despite technological progress, the high cost associated with coronary stent procedures remains a key restraint. Expenses related to stent devices, catheterization laboratories, skilled interventional cardiologists, and post-procedural care can limit accessibility—particularly in low- and middle-income regions. Cost pressures may also influence hospital purchasing decisions, restricting the adoption of advanced stent technologies and limiting procedural volumes.
Technological Advancements Creating New Growth Opportunities
Ongoing innovation in stent design is a major growth catalyst for the coronary stents market. Developments in bioresorbable stents, polymer-coated drug-eluting stents, and next-generation metallic alloys have improved biocompatibility, reduced restenosis rates, and enabled faster patient recovery. Nanotechnology-based coatings and optimized drug-release mechanisms are further enhancing clinical outcomes.
Rapid economic development and rising healthcare investments in emerging economies such as India, China, and Brazil are creating significant growth opportunities. Collaboration between stent manufacturers and healthcare providers is also accelerating product customization, cost optimization, and clinical adoption. Such partnerships enable manufacturers to better address patient-specific needs while improving procedural efficiency and affordability.
Coronary Stents Market Segmentation
By Type
Based on type, the coronary stents market is segmented into Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents, and Covered Stents. Drug-eluting stents dominated the market in 2024 and are expected to maintain the largest share throughout the forecast period due to their proven efficacy in reducing restenosis and repeat interventions.
Bioresorbable stents represent a promising innovation, designed to gradually dissolve after restoring vessel patency, leaving no permanent implant behind. These stents aim to improve long-term vascular function and reduce complications associated with permanent metallic implants, although further clinical validation is ongoing.
By Biomaterial
By biomaterial, the market is segmented into metallic, polymeric, and natural biomaterials. Metallic biomaterials accounted for the largest market share in 2024, supported by their mechanical strength, durability, and established clinical track record. At the same time, advances in biodegradable polymer coatings are improving drug delivery and long-term biocompatibility, reducing the risks associated with permanent implants.
By End User
By end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), and Cardiac Centers. Hospitals dominated the market in 2024 due to their advanced infrastructure and ability to manage complex coronary interventions. However, ambulatory surgical centers are expected to grow at the fastest CAGR, supported by the increasing adoption of minimally invasive and elective PCI procedures in outpatient settings.
Advancements in stent safety and procedural efficiency have enabled same-day discharge for selected patients, reducing hospital stays and overall healthcare costs. Findings presented at the American College of Cardiology annual scientific session highlighted the safety and effectiveness of outpatient PCI in appropriately selected cases.
To access more details regarding this research, visit the following webpage: https://www.stellarmr.com/report/coronary-stents-market/2685
Regional Analysis
North America Leads the Global Market
North America accounted for approximately 43.6% of the global coronary stents market in 2024 and is expected to maintain its leadership during the forecast period. The region benefits from a high prevalence of cardiovascular disease, early adoption of advanced medical technologies, strong reimbursement policies, and a well-established interventional cardiology ecosystem.
Ongoing research into nanotechnology-enabled stents and next-generation drug delivery systems continues to enhance treatment outcomes, reinforcing North America’s dominant position.
Competitive Landscape
The coronary stents market is highly competitive, characterized by continuous innovation, strategic partnerships, and strong R&D investment. Market leaders such as Abbott Laboratories and Boston Scientific Corporation maintain strong positions through diversified cardiovascular portfolios and advanced minimally invasive technologies. While Abbott leverages its broad global footprint, Boston Scientific focuses on specialized interventional solutions supported by robust research capabilities.
Other prominent players include Medtronic plc, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, and Terumo Corporation. Competition is intensifying as companies invest in biodegradable stents, AI-enabled procedural tools, and cost-effective solutions for emerging markets.
Explore Our Top Trends :
Australia Ivf Services Market https://www.stellarmr.com/report/Australia-IVF-Services-Market/1590
Australia Epharmacy Market https://www.stellarmr.com/report/Australia-ePharmacy-Market/1595
Market Outlook
With cardiovascular disease remaining a leading cause of mortality worldwide, the demand for effective coronary revascularization solutions is expected to remain strong. Continued innovation in stent materials, drug delivery, and minimally invasive techniques—combined with expanding access to interventional cardiology in emerging economies—will drive sustained growth in the global coronary stents market through 2032.
About Stellar Market Research:
Stellar Market Research is a global leader in market research and consulting services, specializing in a wide range of industries, including healthcare, technology, automobiles, electronics, and more. With a team of experts, Stellar Market Research provides data-driven market insights, strategic analysis, and competition evaluation to help businesses make informed decisions and achieve success in their respective industries.
For more information, please contact:
Stellar Market Research:
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud, Pune,
Pune, Maharashtra, 411029
+91 20 6630 3320, +91 9607365656
